Abbott clinical biochemical total bilirubin test group - Taiwan Registration 10ef7448304caa0a9099bc8a887c9af1
Access comprehensive regulatory information for Abbott clinical biochemical total bilirubin test group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 10ef7448304caa0a9099bc8a887c9af1 and manufactured by ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC.. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including ABBOTT LABORATORIES, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10ef7448304caa0a9099bc8a887c9af1
DHA00601827700
Product Details
Quantitative testing of total bilirubin in serum or plasma of adults and newborns.
A Clinical chemistry and clinical toxicology
A.1110 Bilirubin (total or direct) test system
Contract manufacturing;; input
Dates and Status
Jun 05, 2007
Jun 05, 2027

